Clinical trial
Evaluating the Safety, Tolerability, Pharmacokinetics and Receptor Occupancy of BMS-984923
NCT04805983
Study timeline
Study start (actual)2021-03-25Date precision: day
Registry last updated2024-08-27
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Alzheimer Diseaseunresolved
Interventions
BMS-984923DRUG
Sponsors & collaborators
Yale Universitylead sponsor
National Institute on Aging (NIA)collaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT04805983 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.